Frederic Boned - Feb 8, 2023 Form 4 Insider Report for BALCHEM CORP (BCPC)

Role
SVP/GM, Human Nutri. & Health
Signature
/s/ Travis Larsen, Attorney in Fact for Frederic Boned
Stock symbol
BCPC
Transactions as of
Feb 8, 2023
Transactions value $
$0
Form type
4
Date filed
2/10/2023, 05:11 PM
Previous filing
Nov 3, 2022
Next filing
Feb 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCPC Common Stock Award $0 +770 +25.48% $0.00 3.79K Feb 8, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Option Award $0 +2.6K $0.00 2.6K Feb 8, 2023 Common Stock 2.6K $138.09 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2 Includes acquisition of shares under the Balchem Corporation 401(k) plan.
F3 Options vest 20% Year 1; 40% Year 2: and 40% Year 3.

Remarks:

Exhibit 24 - Power of Attorney is attached.